
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.

The MicroPort Firehawk Rapamycin Target Eluting Coronary Stent System (REF RV2733) is a 2.75 mm x 33 mm drug-eluting coronary stent pre-mounted on a rapid exchange (Rx) delivery catheter. The Firehawk platform features a cobalt-chromium stent scaffold with abluminal grooves designed to carry a targeted, low-dose rapamycin formulation in a biodegradable polymer, intended to support controlled drug release while minimizing residual polymer load.
Key Features
- Targeted abluminal drug delivery: Laser-cut grooves on the outer (vessel-facing) surface localize the rapamycin and biodegradable polymer coating.
- Low-dose rapamycin: Engineered to deliver a reduced overall drug dose compared with conventional fully-coated DES designs.
- Biodegradable polymer carrier: Designed to resorb after drug release, leaving a polymer-free cobalt-chromium scaffold.
- Cobalt-chromium alloy scaffold: Thin-strut design intended to support deliverability and conformability.
- Rapid exchange delivery system: Compatible with standard interventional workflows for coronary stent deployment.
- Pre-mounted, sterile, single-use: Supplied ready for use in the cath lab.
Clinical Applications
- Percutaneous coronary intervention (PCI) procedures using drug-eluting stent technology.
- Treatment of de novo coronary artery lesions where a 2.75 mm diameter, 33 mm length stent is appropriate per the operator's assessment and the official Instructions for Use.
- Hospital cardiac catheterization laboratories, interventional cardiology programs, and group purchasing organizations sourcing coronary DES inventory.
- Indications, contraindications, warnings, and patient selection criteria are defined by the manufacturer's official IFU and applicable local regulatory clearances.
Product Information
- Brand: MicroPort
- Product family: Firehawk Rapamycin Target Eluting Coronary Stent System
- REF / UPN: RV2733
- Category: Coronary Stents (Drug-Eluting)
- Stent diameter: 2.75 mm
- Stent length: 33 mm
- Scaffold material: Cobalt-chromium alloy
- Drug: Rapamycin (sirolimus) in biodegradable polymer, abluminal groove delivery
- Delivery system: Rapid exchange (Rx) catheter
- Guidewire compatibility: Not specified in the located sources
- Guide catheter compatibility: Not specified in the located sources
- Strut thickness: Not specified in the located sources
- Sterilization: Sterile, single-use device
- Regulatory status: Refer to manufacturer documentation and local regulatory clearances applicable to the destination market.
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.